“New” Nalts Video Resurfaces: “Enlightened Stupid Marketer”
Kevin Nalts (aka Kevin Nalty, former Merck Marketing Director), self-proclaimed YouTube comedian and "viral video genius," revealed to me a video piece he did about a year ago that remained private...
FDA Rules are NOT Media Agnostic
FDA has just released a new draft guidance document: "Presenting Risk Information in Prescription Drug and Medical Device Promotion" (find the pdf file here).I haven't read the guidance yet, but according...
Live Podcast Today: Towards a Rational FDA Policy Addressing the Internet and Social Media
Arnold Friede, Counsel to the law firm McDermott Will & Emery LLP, talks about organizing a collective response from representatives of the pharma industry to FDA's recent enforcement initiative on the...
Nalts Talks About His Days at J&J, His ADHD, and His Merck Performance Review
Kevin Nalty (aka "Nalts" the YouTube video blogger), who last week decided to quit his job as Consumer Product Director at Merck to "follow his passion" for video, may have been...
Was Nalty’s Fart Video the Straw that Broke Merck’s Back or was it Some...
Kevin Nalty (aka "Nalts" the YouTube video blogger) told NewTeeVee's Liz Gannes that "the fact that Merck was recently being unfairly linked to me and fart videos was the ’straw that...
Kevin Nalty Goes Nalts Full Time! Quits Merck to Become Online Video Marketer
May 21, 2009: "Today I quit my day job as Consumer Product Director at Merck, where I marketed Propecia," announced Kevin Nalty, aka YouTube comedian "Nalts." "Thanks to all of my...
The Real Agenda of GSK’s New Blog and Why the Authors’ Identities are Cloaked
The world's second largest drug company, GSK, has followed the lead of the world's most trusted drug company (J&J) and entered the blogosphere and Twitterdom.The blog, American Health: More Than Medicine,...
Will the Drug Industry be the Next Auto Industry?
At last night's Philama (Philadelphia American Marketing Association PharmaSIG) panel discussion on "Pharmaceutical Marketing within Today's Social Media Culture -- Opportunity or Nightmare?" I found myself comparing the pharmaceutical industry to...
Behrman Wasn’t the First Patient Spokesperson Paid Big Bucks By BMS
Andy Behrman -- aka "Electroboy" -- is being raked over the coals for first shilling for BMS' drug Abilify (for which BMS paid him $400,000), then "shaking down" BMS for a...
Andy Behrman, Now an Anti-BMS Spokesperson, Says “Ask Your Doctor If Abilify is Wrong...
The saga of the Andy Behrman, the patient that Bristol-Myers Squibb (BMS) paid hundreds of thousands of dollars (but balked at paying him millions) to help promote its drug Abilify, continues.?...








![6 Digital Tools at the Center of Healthcare Digitalization [INFOGRAPHIC]](http://ec2-54-175-84-28.compute-1.amazonaws.com/pharma-mkting.com/wp-content/uploads/2021/04/6DigitalTools_600px-100x70.jpg)



